BioMarin Pharmaceuticals BMRN Royalty and other revenues — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's royalty and other revenues — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's royalty and other revenues — total revenues?
- BioMarin Pharmaceuticals (BMRN) reported royalty and other revenues — total revenues of $6.13M in Q1 2026.
- How has BioMarin Pharmaceuticals's royalty and other revenues — total revenues changed year-over-year?
- BioMarin Pharmaceuticals's royalty and other revenues — total revenues decreased by 41.6% year-over-year, from $10.5M to $6.13M.
- What is the long-term trend for BioMarin Pharmaceuticals's royalty and other revenues — total revenues?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's royalty and other revenues — total revenues has grown at a -3.9% compound annual growth rate (CAGR), from $62.78M to $53.49M.
- What does royalty and other revenues — total revenues mean?
- Total income earned from royalties, licensing deals, and other non-product-sale commercial activities.
- How do you interpret royalty and other revenues — total revenues?
- An increase suggests successful monetization of intellectual property or expanded licensing partnerships, while a decrease may indicate expiring patents or reduced third-party sales performance.
- How does royalty and other revenues — total revenues compare across companies?
- Similar to 'Other Revenue' or 'Royalty Income' reported by other biopharmaceutical companies, which often fluctuates based on the lifecycle of licensed assets and contractual milestone schedules.